Glaukos Corp (GKOS) is a Healthcare · Medical Devices company listed on NYSE. Price $159.22 (-1.36%), Market cap $8.46B, 52-week low–high $74.67 ~ $144.01.
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with
Financial statements, price targets, institutional (13F) holdings and related news for Glaukos Corp are updated in real time on BlackAll Trade.
Glaukos Corp trades at $159.22 (-1.36%). Real-time quotes and charts are available on BlackAll Trade.
Glaukos Corp has a market cap of about $8.46B.
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and int